An integrative approach to predicting the functional effects of non-coding and coding sequence variation by Shihab, H. A. et al.
Genome analysis
An integrative approach to predicting the
functional effects of non-coding and coding
sequence variation
Hashem A. Shihab1,2,*,†, Mark F. Rogers3,*,†, Julian Gough4,
MatthewMort5, David N. Cooper5, Ian N. M. Day2, Tom R. Gaunt1,2,† and
Colin Campbell3,*,†
1MRC Integrative Epidemiology Unit (IEU), University of Bristol, Bristol BS8 2BN, UK, 2Bristol Centre for Systems
Biomedicine, University of Bristol, Bristol BS8 2BN, UK, 3Intelligent Systems Laboratory, University of Bristol,
Bristol BS8 1UB, UK, 4Department of Computer Science, University of Bristol, Bristol BS8 1UB, UK and 5Institute of
Medical Genetics, Cardiff University, Cardiff CF14 4XN, UK
*To whom correspondence should be addressed.
Associate Editor: Alfonso Valencia
†The authors wish it to be known that, in their opinion, the first two and last two authors should be regarded as joint Authors.
Received on September 3, 2014; revised on December 30, 2014; accepted on January 5, 2015
Abstract
Motivation: Technological advances have enabled the identification of an increasingly large spec-
trum of single nucleotide variants within the human genome, many of which may be associated
with monogenic disease or complex traits. Here, we propose an integrative approach, named
FATHMM-MKL, to predict the functional consequences of both coding and non-coding sequence
variants. Our method utilizes various genomic annotations, which have recently become available,
and learns to weight the significance of each component annotation source.
Results: We show that our method outperforms current state-of-the-art algorithms, CADD and
GWAVA, when predicting the functional consequences of non-coding variants. In addition,
FATHMM-MKL is comparable to the best of these algorithms when predicting the impact of coding
variants. The method includes a confidence measure to rank order predictions.
Availability and implementation: The FATHMM-MKL webserver is available at: http://fathmm.
biocompute.org.uk
Contact: H.Shihab@bristol.ac.uk or Mark.Rogers@bristol.ac.uk or C.Campbell@bristol.ac.uk
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Rapid technological advances and the falling costs of next-gener-
ation sequencing technologies have accelerated the identification of
single nucleotide variants (SNVs) in the human genome (The 1000
Genomes Project, 2010). Ascertaining which of these are functional,
against a background of neutral SNVs, promises to improve our
understanding of the molecular mechanisms underpinning disease
and complex traits. There is a plethora of computational algorithms
capable of predicting whether SNVs are deleterious (Thusberg et al.,
2011). However, these algorithms are typically restricted to SNVs
falling within protein-coding regions of the genome, with a particu-
lar focus on non-synonymous SNVs (nsSNVs). They are therefore
incapable of assessing the consequences of a significant proportion
of SNVs, given that the vast majority of SNV-trait associations fall
within intergenic or intronic regions of the genome (Hindorff et al.,
2009). In this article, we propose a method for predicting the func-
tional impact of both coding and non-coding SNVs.
Existing protein-based prediction algorithms tend to exploit evolu-
tionary conservation when determining whether or not variants are
functional. However, other potential sources for functional annotation
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are also now available from the Encyclopaedia of DNA Elements
(ENCODE) consortium. Using several different technologies,
ENCODE aims to identify all functional elements within the human
genome, including transcribed non-coding RNAs, transcription factor
binding sites and chromatin structure (The ENCODE Project
Consortium, 2012). At the time of writing, ENCODE has produced
approximately 1640 datasets describing the analysis of 24 different
types of experiments in 147 cell lines, under various conditions (Qu
and Fang, 2013). One of the major challenges faced by researchers is
to successfully integrate the wealth of information contained within
ENCODE to predict the functional consequences of SNVs.
Following our previous work (Shihab et al., 2013b, a, 2014), we
describe a machine learning approach (called FATHMM-MKL) that
integrates functional annotations from ENCODE with nucleotide-
based sequence conservation measures. When assessing the func-
tional consequences of non-coding variants, we observe improved
performance when compared with two recently proposed variant
prediction algorithms: GWAVA (Ritchie et al., 2014) and CADD
(Kircher et al., 2014), which as far as we are aware, are the only
other proposed methods that can predict the functional conse-
quences of non-coding variants. Furthermore, our method achieves
comparable performance to CADD when predicting the functional
impact of nsSNVs. A web-based implementation of FATHMM-
MKL, including pre-computed predictions for the entire human
genome and downloadable software, is available at http://fathmm.
biocompute.org.uk.
2 Methods and materials
2.1 Datasets
We assembled two distinct datasets: our pathogenic dataset was
constructed using heritable germ-line mutations from the Human
Gene Mutation Database (Stenson et al., 2014) (release 2013.4, sub-
sequently denoted HGMD) and our control dataset was constructed
using SNVs from the 1000 Genomes Project (The 1000 Genomes
Project Consortium, 2012). This control dataset will contain many
variants that are unannotated, and therefore it will likely contain
some true positives. We will consider this issue in more detail in
Section 3.3. Similarly, among positively labelled datapoints from the
HGMD dataset, we could expect some true negatives: some neutral
variants can be inherited alongside pathogenic variants due to gen-
omic proximity, for example. Thus the positive class should be
viewed as disease-associated variants that are enriched for func-
tional impact as a set. The method we are to describe can be used
with datasets for both inherited single nucleotide polymorphisms
(SNPs) and somatic SNVs. The HGMD dataset is therefore an
example of the former category.
For our analysis, we restricted our control dataset to SNVs hav-
ing a global minor allele frequency 1% and further removed those
that were also present in our pathogenic dataset. In order to assess
the predictive utility of our method in both coding and non-coding
regions of the genome, we further split our pathogenic and control
datasets according to whether or not the variant introduces an
amino acid substitution. We used 10 feature groups, denoted [A–J],
which could be predictive of disease association and are therefore
used to annotate out datasets using a customized pipeline. These fea-
ture groups are more fully described in the Supplementary material,
but a short description is as follows:
A. 46-Way Sequence Conservation: based on multiple sequence
alignment scores, at the nucleotide level, of 46 vertebrate gen-
omes compared with the human genome.
B. Histone Modifications (ChIP-Seq): based on ChIP-Seq peak calls
for histone modifications.
C. Transcription Factor Binding Sites (TFBS PeakSeq): based on
PeakSeq peak calls for various transcription factors.
D. Open Chromatin (DNase-Seq): based on DNase-Seq peak
calls.
E. 100-Way Sequence Conservation: based on multiple sequence
alignment scores, at the nucleotide level, of 100 vertebrate gen-
omes compared with the human genome.
F. GC Content: based on a single measure for GC content calcu-
lated using a span of five nucleotide bases from the UCSC
Genome Browser.
G. Open Chromatin (FAIRE): based on formaldehyde-assisted iso-
lation of regulatory elements (FAIRE) peak calls.
H. Transcription Factor Binding Sites (TFBS SPP): based on SPP
peak calls for various transcription factors.
I. Genome Segmentation: based on genome-segmentation states
using a consensus merge of segmentations produced by the
ChromHMM and Segway software.
J. Footprints: based on annotations describing DNA footprints
across cell types from ENCODE.
2.2 Data integration
The resulting product of this data preparation is several large matri-
ces comprising data from different feature groups, each of which
can have different measurement scales. These feature groups can all
indicate whether an SNV is functional or not, and hence we use a
classifier based on multiple kernel learning (MKL). In MKL, differ-
ent types of input data are encoded into kernel matrices, which
quantify the similarity of data objects. A number of different meth-
ods have been proposed for deriving kernel matrices for different
types of data objects, including data with discrete and continuous
values, sequence data and graph data (Shawe-Taylor and
Cristianini, 2004). With MKL, each constituent type of data is
encoded into a corresponding base kernel K‘ (where ‘ ¼ 1; . . . ; p if
there are p feature groups), from which we can derive a composite
kernel matrix K ¼Pp‘¼1 k‘K‘ where
Pp
‘¼1 k‘ ¼ 1 and k‘ 0. The k‘
are kernel weights. This composite kernel can then be used with a
kernel-based classifier, such as a support vector machine (SVM)
(Campbell and Ying, 2011), which was the classifier used here.
During the training phase, this approach requires determination
of the learning parameters for the SVM in addition to the
kernel weights. A variety of methods have been proposed for MKL
(Go¨nen and Alpaydin, 2011), and this approach has been success-
fully demonstrated with various classification problems in bioinfor-
matics, which use different types of input data (Ying et al., 2009).
By using all available data encoded into a set of kernels, MKL
classifiers most frequently outperform a single kernel classifier
constructed for one type of data. In addition, the kernel weights are
adjusted according to the relative informative-ness of the different
types of data: this enhances overall performance and interpretation
of the model.
As further explained in the Supplementary Material, we also
introduce a confidence measure associated with predicted class
label. An SVM for binary classification has a decision function
of the form signð/Þ with the sign of / determining the predicted
class. However, the magnitude j/j is also a measure of the confi-
dence in this class assignment. By fitting a sigmoid function, we
convert / into a confidence measure based on the posterior prob-
ability of a positive (pathogenic) outcome P(y¼1j/) (Platt,
1999). Apart from indicating the reliability of a prediction, this











confidence measure can be used to rank predictions and to fur-
ther enhance predictive accuracy via cautious classification, i.e.
by restricting predictions to high confidence instances, we achieve
greater accuracy, but at the expense of only making predictions
on a fraction of variants. Using a P-value (posterior probability
value) cutoff, we can isolate a subset of predictions with higher
reliability for subsequent experimentation. In order to compare
predictive test accuracies, we report our results using receiver
operating characteristic (ROC) curves and associated area under
the curve (AUC) measures for both non-coding and coding
variants.
2.3 Predicting the effects of non-coding variants
Our non-coding dataset was substantially imbalanced, yielding
more than 6.7 million negative examples and 12 438 positive ex-
amples (annotated disease-causing mutations). As noted by Ritchie
et al. (2014), examples from the HGMD database are not distrib-
uted uniformly across the genome, and it is unlikely that the genes
associated with these positive examples represent an unbiased sam-
ple. To mitigate potential bias, and to facilitate a comparison with
GWAVA, we used the strictest data selection procedure outlined in
Ritchie et al. (2014), i.e. selecting negative examples that fall within
a 1000-nt window of some positive example. This reduces our pool
of negative examples from several million to 24 064. Furthermore,
in order to assemble a training dataset for our MKL classifier, we
required training examples with at least one value in each of our fea-
ture groups. Unfortunately, data can be absent from some feature
groups for a given training example. Therefore, we could in prin-
ciple use a larger number of feature groups, which would result in
fewer training examples, or we could use a smaller number of fea-
ture groups, but with many more training examples. If we used a
10-feature group model [A–J], this requirement restricted our data-
set to 1372 negative examples and just 913 positive examples.
However, if instead we opted to use four feature groups (see the
Supplementary data for how these groups were selected), this
yielded a dataset comprising 5252 negative examples and 3063 posi-
tive examples for training and testing. As noted in the
Supplementary data, the final version of our algorithm uses four
feature groups [A–D].
We compared our method to two state-of-the-art methods for
predicting non-coding deleterious mutations: GWAVA (Ritchie
et al., 2014) and CADD (Kircher et al., 2014). CADD is a database
of pre-computed scores. As with our method, CADD is based on
use of a SVM classifier. CADD also integrates different annotations
to create a single score (C-score), though it does not use an algorith-
mic procedure to weight different annotations according to rele-
vance, unlike our approach. Though the C-scores derived within
CADD quantify extent of pathogeneity, the derivation of these
scores is distinct from the probability measures we introduce in this
article. To ensure a fair comparison, we restricted our test data to
those examples that appear in the CADD database. GWAVA is a
random forest classifier that makes predictions for novel SNVs
based on training data that are included with the software.
Prediction on any of GWAVA’s training examples should be trivial
and represents the training error, which does not estimate how well
GWAVA generalizes to new variants. So we omitted those examples
from our test set. This final filtering step reduced our test data
from 8315 examples to 7623 examples (4591 negative and 3032
positive) for comparing our method with these alternatives. This re-
sultant dataset provided enough examples to perform 5-fold cross-
validation with 4800 examples for training and 1200 examples for
testing in each fold.
In an experimental setting, we may also want to know the confi-
dence associated with a particular prediction and the potential ac-
curacy at a given confidence level. Therefore, we also associated a
confidence measure with each prediction and considered restricting
predictions to those instances where the associated confidence meas-
ure exceeds a given P-value cutoff, see the Supplementary data for
details.
2.4 Predicting the effects of coding variants
In total, 87 518 coding examples were available, consisting of
67 305 positive and 20 213 negative examples. However, missing
values in some feature groups and the requirement of a balanced
dataset reduced the size of the training dataset. Using 10 feature
groups, [A–J], it was possible to construct a balanced training data-
set of 1073 positive and 1073 negative examples, from a set of 2714
positive and 1073 negative examples. If we use four feature groups
[A–D], we could use a balanced set of 3000 positive and 3000 nega-
tive examples for training, from a set of 17 362 positive and 4853
negative examples. Using 5-fold cross-validation, the remaining data
were used as the test set in both cases. We did not apply the restric-
tion that negative examples must be located within a thousand
nucleotides of positive examples (this would have resulted in too
few negative training examples).
3 Results
3.1 Performance of the method: non-coding variants
We found that a MKL model with the four most distinct feature
groups (Figs. 1 and 2 with an AUC of 0.91) gave better performance
than a model with all 10 feature groups (Supplementary Figs. S1 and
S2 with an AUC for MKL of 0.85). We discuss the selection of these
four feature groups in the Supplementary data. In experiments with
this 4-feature group model, we found that feature group A, based on
conservation scores from the alignment of 46 vertebrate genomes
to the human genome, yielded the strongest performance of any in-
dividual kernel. It had an average AUC score of 0.88 (Fig. 1). The
other feature groups yielded weaker performance with individual
AUC scores ranging from 0.55 to 0.61. These scores are reflected in
Fig. 1. Five-fold cross-validation performance using the non-coding dataset
and four feature groups (see Supplementary data [A–D]). ROC curves
for FATHMM-MKL and classifiers using only one type of data. Even weak-
performing feature group classifiers may contribute discriminatory informa-
tion to the weighted aggregate MKL classifier, which outperforms any of the
individual feature group classifiers











the MKL kernel weights (Supplementary Fig. S3). The weight for
46-way conservation is 0.71, whereas the second most informative
feature group, TFBS Peak-Seq, receives a weight of 0.26. However,
we found that MKL detects some additional discriminative power
within the two weakest-performing feature groups with non-zero
kernel weights of 0.004 and 0.03. The contribution of these weaker
groups is evident from the overall MKL performance, which
achieved an AUC score of 0.91 (Fig. 1). We obtained CADD scores
by downloading files from their website and querying mutations
using Tabix (Li, 2011); for GWAVA scores, we compared results
from all three of the GWAVA models (region, tss and unmatched)
and report those that yielded the highest accuracy in our tests. Our
MKL classifier (FATHMM-MKL) yielded a significant performance
improvement over both GWAVA (region) and CADD (Fig. 2).
Performing a non-parametric test (simple binomial sign test) on the
AUC scores across the 5-folds (FATHMM-MKL versus CADD), the
difference in predictive accuracy is significant for all folds and
the probability is 0.03125 that there is no statistical difference.
When we apply cautious classification to our classifier, we can
achieve near-perfect classification accuracy at the highest P-value
cutoffs (Figs. 3 and 4). For predictions with 90% confidence or
greater, the classifier achieves a 96% test accuracy while making
predictions for nearly 40% of examples, while at 95% confidence,
the accuracy increases to 98% with nearly 16% of examples having
label predictions (Fig. 3).
3.2 Performance of the method: coding variants
Unlike our non-coding dataset, we found that an MKL model with
all 10 discriminative feature groups (Figs. 5 and 6 with an AUC of
0.93) gave better performance than a model with the top four fea-
ture groups (Supplementary Figs. S4 and S5 with an AUC for MKL
of 0.91). This superior performance with 10 feature groups was
achieved despite using only 2146 training examples in contrast to
the 6000 training examples used with the four-feature group model.
We found that FATHMM-MKL was comparable to CADD on the
same dataset (Fig. 6). Further, cautious classification gave similar
curves to those for the non-coding data (Figs. 3 and 4), see
Supplementary Figures S6 and S7.
3.3 Performance of method: prediction across
all nucleotides in the human genome
3.3.1 Prediction across the whole genome
Next, we evaluated the prediction performance of FATHMM-MKL
across a wider spectrum of the human genome (results for the entire
human genome are available at the associated website). Across the
wider genome, many ‘neutral’ (unannotated) variants may be true
Fig. 2. Five-fold cross-validation performance using the non-coding dataset
and four feature groups (see Supplementary data [A–D]). ROC curves indicat-
ing that FATHMM-MKL yields substantially better predictive performance
relative to CADD or GWAVA on the same examples
Fig. 3. Five-fold cross-validation performance using the non-coding dataset
and four feature groups (see Supplementary data [A–D]). Cautious classifica-
tion yields nearly perfect performance as we increase the P-value cutoff (test
accuracy as a fraction versus P-value cutoff)
Fig. 4. Five-fold cross-validation performance using the non-coding dataset
and four feature groups (see Supplementary data [A–D]). The breakdown of
true positive (TP), true negative (TN), false positive (FP) and false negative
(FN) predictions for cautious classification shows that TP and TN predictions
remain robust up to the highest P-value cutoffs (based on 5-fold cross-
validation, the average number of test predictions from 1200 is 469.0 at a 90%
cutoff and 195.4 at a 95% cutoff)
Fig. 5. Five-fold cross-validation performance using the coding dataset and
10 feature groups (Supplementary [A–J]). ROC curves for FATHMM-MKL and
for classifiers using only one type of data











functional variants that are not reported because (i) they haven’t
been tested against a relevant phenotype or (ii) their effects are
subtle and haven’t been detected. In this section, we will explore the
potential for FATHMM-MKL to correctly predict novel functional
mutations and compare its behaviour with that of CADD and
GWAVA across the entire human genome.
As noted earlier, our total of labelled variants consisted of
67 56 202 neutral and 12 438 positive non-coding examples, giving
a total of 67 68 640. Of these, 65 07 401 had at least one of the four
feature groups necessary to make a prediction (64 98 026 neutral
and 9375 positive), which we used as our validation set. For many
of these examples, we were not able to obtain data for all of our fea-
ture groups. In these cases, we used only the feature groups we had
and rescaled the associated kernel weights by setting the missing ker-
nel weights to 0 and the remaining weights k0‘ ¼ k‘=
P
‘ k‘. We com-
pared our predictions for the same 6.5 million positions in the
CADD database and to predictions from the GWAVA software
tool. Both FATHMM-MKL and GWAVA yield scores in the range
[0, 1], while the CADD database provides a raw decision function
value along with an encoded ranking of its scores. In all cases, the
higher the score, the greater the confidence of a functional mutation.
Conversely, the lower the score, the greater the confidence that a
mutation is neutral. Given this vastly unbalanced test dataset, we
focused our evaluations on false-positive rates, using optimal thresh-
olds for each method.
To find optimal thresholds, we iterated threshold values over the
entire range of scores for each method. At each threshold we
counted scores below the threshold as negative predictions and those
at or above the threshold as positive. This allowed us to count true-
positive, false-positive, true-negative and false-negative predictions
for computing the balanced accuracy and the false-positive rate at
each threshold. We also evaluated FATHMM-MKL at its intended
threshold of 0.5. Figures 7 and 8 show the test accuracy curves for
FATHMM-MKL and for CADD at different threshold values (raw
scores for CADD and P-values for FATHMM-MKL). CADD’s ac-
curacy peaks at a threshold of 0.73, achieving balanced accuracy of
87.6% while yielding a false-positive rate of 9.3%. FATHMM-
MKL exhibits a nominal peak at 0.26, achieving balanced accuracy
of 90.5% with a false-positive rate of 7.2%. At its default threshold
of 0.5, FATHMM-MKL’s accuracy drops to 89.6% but with a dra-
matic drop in false-positive rate to 3.8%. GWAVA (region model)
reached a peak accuracy of 67.7% at a threshold of 0.38, with a
false-positive rate of 16.7% (Supplementary Fig. S8). We also com-
pared the number of false-positive predictions at the highest confi-
dence levels for each method. FATHMM-MKL yielded 4 84 780
false-positives at its optimum threshold, 2 58 840 false-positives at
its default threshold of 0.5, 96 408 at P-values above 0.90, 50 357
above 0.95 and 1870 above 0.99. CADD had 6 29 370 false-posi-
tives at its optimal threshold, 3 54 264 false-positives ranked in the
top 10% of its predictions, and 23 563 ranked in the top 1%
(encoded rank values above 10 and 20, respectively).
We recall that for training we selected negative examples from
regions within 1 K of some annotated deleterious example. Hence,
the negative examples in our validation set consist almost entirely of
examples outside these 1 K regions. In addition, the false-positive
predictions on our validation set represent just 4–7% of negative
examples. Thus, we consider the possibility that many of the
Fig. 6. Five-fold cross-validation performance using the coding dataset and 10
feature groups (Supplementary [A–J]). ROC curves indicating that FATHMM-
MKL yields comparable performance relative to CADD the same examples
Fig. 7. Evaluation of accuracy and false-positive counts for FATHMM-MKL on
the full set of known examples from the 1000 Genomes and HGMD (evaluated
on both coding and non-coding variants). FATHMM-MKL exhibits a nominal
peak at 0.26, achieving balanced accuracy of 90.5% while yielding a false-
positive rate of 7.2%. At its default threshold (0.5), FATHMM-MKL’s accuracy
drops to 89.7% but with a dramatic drop in false-positive rate to 3.8%. Its ac-
curacy remains over 88% up to a threshold of 0.92, with the false-positive rate
dropping to just 1.2%
Fig. 8. Evaluation of accuracy and false-positive counts for CADD, for com-
parison with FATHMM-MKL, depicted in Figure 7. CADD’s accuracy peaks at
a threshold of 0.73, achieving balanced accuracy of 87.6% while yielding a
false-positive rate of 9.3%. However, as its false-positive rate declines notice-
ably above this threshold, so does its accuracy











false-positive predictions could be true positives, i.e. that they are
mis-annotated. To explore this possibility further, in Figure 9, we
plot the distribution of minor allele frequencies for our predicted
high-scoring false-positives against the distribution of all neutral ex-
amples at a P-value confidence of 0.95 or higher. These high-scoring
false-positives have a distribution that is shifted towards lower
frequencies (this trend gradually diminishes as the P-value cutoff is
reduced). Through evolution, common variants are unlikely to be
associated with disease and it is rare variants, which are likely to be
the main source of functional impact. An individual prediction
should not be biased towards these rare variants. Consequently, the
higher incidence of false positives among rarer variants suggests
the false positive set in the data is actually enriched with some
mislabelled true positives.
3.3.2 Comparison with ClinVar data
We further evaluated FATHMM-MKL on data from the ClinVar
database (Landrum et al., 2013). This same resource was used to
validate both GWAVA and CADD so was an ideal source of novel
examples for comparing these methods (Ritchie et al., 2014; Kircher
et al., 2014). Using the most recent dataset (August 8, 2014), we ex-
tracted records labeled either as benign or pathogenic (CLNSIG
codes 2 and 5, respectively) and removed those found in our training
data. This yielded sets of 647 non-coding and 3520 coding muta-
tions that were unknown to FATHMM-MKL. Consistent with our
other experiments, we found that FATHMM-MKL outperformed
the other methods substantially on non-coding data (Fig. 10), with
an AUC of 0.93 compared with 0.89 for CADD and 0.62 for
GWAVA (region model). This gives us confidence that FATHMM-
MKL will generalize robustly to other non-coding regions of the
genome, where a vast number of novel deleterious SNVs are likely
to be discovered. Classification on coding examples was somewhat
weaker: FATHMM-MKL achieved a ROC of 0.80 compared with
0.88 for CADD and 0.56 for GWAVA (unmatched model). We
speculated that this performance may be due to examples that were
missing data for some of the FATHMM-MKL feature groups: of the
3520 coding examples, only 157 (4.5%) had data in all 10 feature
groups. When we restricted our evaluation only to examples with
data for all features, FATHMM-MKL’s performance improved
substantially (red line, bottom of Fig. 10), once again comparable
to CADD’s. This highlights a tradeoff between the accuracy we
can achieve by using many sources of evidence, and a possible
decrease in the number of confident predictions we make from those
sources.
3.3.3 Novel HGMD examples
Finally, the positive examples for our training dataset were derived
from release 2013.4 of the Human Gene Mutation Database.
During the interval after we constructed and tested the classifier,
new datapoints were added to the HGMD (now release 2014.2),
Fig. 9. The normalized count versus minor allele frequency for false-positives
(a labelled negative, predicted positive) and neutrals (a labelled negative,
predicted negative)
Fig. 10. Performance of FATHMM-MKL, CADD and GWAVA on ClinVar ex-
amples for non-coding regions (top) and coding regions (bottom). As in our
other tests, FATHMM-MKL performs substantially better than the other meth-
ods on non-coding examples, suggesting that it will generalize robustly to
non-coding regions of the genome where the vast majority of novel deleteri-
ous SNVs are likely to reside. CADD’s coding classifier performed best over-
all, while both CADD and FATHMM-MKL outperformed GWAVA. When we
considered only examples with data in all 10 feature groups, FATHMM-MKL’s
performance was comparable to CADD’s (FATHMM-MKL full, bottom figure,
red line)











consisting of 2205 novel positive examples from coding regions and
401 from non-coding regions. This gives us an objective test of recall
performance on unseen instances. Of these novel positive examples,
339 non-coding examples (85%) and 1955 coding examples (89%)
are correctly predicted by our classifier at the default threshold.
For some non-coding examples, we had no data in any of the feature
groups and hence FATHMM-MKL could not make a prediction.
When we consider only those examples where predictions can be
made, these proportions increase to 88%. We also found that 34 of
these novel positive examples were labeled negative in our training
data, illustrating the potential prevalence of noise in the data.
In summary, FATHHMM-MKL has distinct advantages over
CADD and GWAVA and the above observations indicate that it
provides reliable predictions with recall near 88%.
3.3.4 FATHMM-MKL website
The associated website allows users to query our prediction data-
base for novel deleterious mutations. In addition, we provide down-
loadable tables of ranked positive predictions (functional in disease)
for three values of the P-value cutoff: at 0.95, 0.90 and at 0.26
(the former are subsets of the latter). Finally, we provide software
for generating predictions given new data in at least one of our
feature groups.
4 Discussion
The method we have outlined outperformed both GWAVA and
CADD when predicting the functional consequences of non-coding
sequence variants (Fig. 2 and Supplementary Fig. S2). In this case,
better performance was achieved using a smaller number of feature
groups ([A–D] in Fig. 1), as opposed to a broader range of feature
groups ([A–J] in Supplementary Fig. S1). We also achieved good per-
formance when predicting the functional impact of nsSNVs (Fig. 6).
For coding sequence variants, better performance was achieved
using all the feature groups ([A–J] in Fig. 5) instead of a smaller
subset of feature groups (e.g. [A–D] in Supplementary Fig. S4). This
out-performance was achieved despite the fact that the 10 feature
group model used only 36% of the training examples available to
the four feature group model. This suggests that a broad range
of data sources are informative for classifying variants in coding re-
gions. For predicting the functional impact of variants in non-coding
regions, the opposite is suggested, with fewer types of data being
truly informative. In both cases, the most informative indicator
is whether or not the variant falls within regions which are highly
conserved across species.
One advantage of our method is that it highlights the relative in-
formative-ness of the different sources of data (e.g. Supplementary
Fig. S3). Furthermore, the addition of a confidence measure also
allows for the isolation of a smaller set of variants that have a higher
confidence of correct functional impact assignment. This provides
an intuitive way to rank predictions for subsequent analysis when
discovering novel deleterious variants, as one may be able to survey
only a small set of the most compelling variants. However, as noted
in Section 3.3.2, incomplete data may restrict the feature groups we
can use to make a prediction. Currently, we rescale kernel weights
to accommodate these cases, but as our experiments with coding ex-
amples reveal, rescaling may not adequately compensate for missing
features. We anticipate that rapidly growing data resources will
mitigate this issue eventually, but immediate improvements in test
accuracy are possible. For example, provided the number of feature
groups remains small, we could learn sets of kernel weights specific
to all possible combinations of feature groups. Feature groups
had between 8 and 443 component features, with the strongest-
performing group having the fewest features (46-way and 100-way
conservation). It may be possible to improve performance using
feature selection within these groups. In addition, rather than inte-
grating component feature groups at the level of the data, via a com-
posite kernel, it would be possible to integrate classifiers (each
handling one feature group), via ensemble learning. Additional im-
provements are possible. For example, for non-coding regions, we
could further exploit the sequence context of a variant to identify a
possible functional element (e.g. a non-coding RNA site) and use
this information to improve predictive accuracy.
In future projects, we shall investigate these potential improve-
ments in addition to devising bespoke predictors for labelling vari-
ants in specific disease contexts, such as cancer. For prediction using
coding variants, there are further sources of data that could be rele-
vant to enhancing prediction performance. We will also experiment
with these to establish if the proposed MKL method could be
improved further, leading to out-performance over CADD.
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